Glenmark gets USFDA nod for anti-hypertension drug

Monday, 20 December 2010, 20:14 IST   |    1 Comments
Printer Print Email Email
New Delhi: Drug firm Glenmark today said it has got approval from U.S. health regulator for its generic Felodipine tablets, an anti-hypertensive drug, in the American market. Glenmark Generics Inc, the company's U.S.-based arm has received final approval from the U.S. Food and Drug Administration (USFDA) for Felodipine extended-release tablets, Glenmark Pharmaceuticals said in a statement. The company has got the approval for the tablets in strengths of 2.5 mg, 5 mg and 10 mg, it added. Felodipine tablets are generic version of Astrazeneca Pharmaceuticals' Plendil. According to IMS Health, Felodipine achieved sales of $97 million in the U.S. market for the 12 months ended September 2010. "The company will commence marketing and distribution immediately in the U.S. and anticipates a successful launch based on the limited competition existing in the market", it said. Shares of Glenmark were trading at Rs 346.
Source: PTI
siliconindia